STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 19 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,171,000 | -67.2% | 490,000 | -57.0% | 0.42% | -61.1% |
| Q2 2019 | $3,568,000 | -37.8% | 1,140,000 | -1.1% | 1.09% | -31.6% |
| Q1 2019 | $5,739,000 | -7.8% | 1,152,500 | -17.1% | 1.59% | -31.6% |
| Q4 2018 | $6,227,000 | -25.8% | 1,390,000 | -19.7% | 2.32% | +8.9% |
| Q3 2018 | $8,390,000 | -23.6% | 1,730,000 | -5.5% | 2.14% | -24.9% |
| Q2 2018 | $10,980,000 | -22.0% | 1,830,000 | +15.1% | 2.84% | -29.4% |
| Q1 2018 | $14,071,000 | +55.3% | 1,590,000 | +27.2% | 4.02% | +38.6% |
| Q4 2017 | $9,062,000 | +11.3% | 1,250,000 | +5.9% | 2.90% | +0.8% |
| Q3 2017 | $8,142,000 | -3.5% | 1,180,000 | 0.0% | 2.88% | -18.3% |
| Q2 2017 | $8,437,000 | +50.5% | 1,180,000 | 0.0% | 3.52% | +26.3% |
| Q1 2017 | $5,605,000 | +101.3% | 1,180,000 | +1.7% | 2.79% | +70.1% |
| Q4 2016 | $2,784,000 | – | 1,160,000 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |